{"id":"https://openalex.org/W2463147286","doi":"https://doi.org/10.1371/journal.pone.0158888","title":"Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma","display_name":"Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma","publication_year":2016,"publication_date":"2016-07-08","ids":{"openalex":"https://openalex.org/W2463147286","doi":"https://doi.org/10.1371/journal.pone.0158888","mag":"2463147286","pmid":"https://pubmed.ncbi.nlm.nih.gov/27391784","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4938529"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0158888","doi":"https://doi.org/10.1371/journal.pone.0158888","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0158888","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158888&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158888&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108739923","display_name":"Satoshi Kawano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Kawano","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba, Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba, Ibaraki, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000162907","display_name":"Alexandra R. Grassian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexandra R. Grassian","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028907649","display_name":"Masumi Tsuda","orcid":"https://orcid.org/0000-0001-5400-5905","observed_orcids":["https://orcid.org/0000-0001-5400-5905","https://orcid.org/0000-0001-8554-0636"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masumi Tsuda","raw_affiliation_strings":["Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan","institution_ids":["https://openalex.org/I205349734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038902590","display_name":"Sarah K. Knutson","orcid":"https://orcid.org/0009-0007-2676-8607","observed_orcids":["https://orcid.org/0009-0007-2676-8607"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah K. Knutson","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056679178","display_name":"Natalie M. Warholic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie M. Warholic","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021756014","display_name":"Galina Kuznetsov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Galina Kuznetsov","raw_affiliation_strings":["Eisai Inc., Andover, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Andover, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113662804","display_name":"Shanqin Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shanqin Xu","raw_affiliation_strings":["Eisai Inc., Andover, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc., Andover, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101797163","display_name":"Yonghong Xiao","orcid":"https://orcid.org/0000-0001-6113-2443","observed_orcids":["https://orcid.org/0000-0001-6113-2443","https://orcid.org/0000-0001-8249-9420"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yonghong Xiao","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004903148","display_name":"Roy M. Pollock","orcid":"https://orcid.org/0000-0002-6182-6725","observed_orcids":["https://orcid.org/0000-0002-6182-6725"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy M. Pollock","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071914301","display_name":"Jesse S. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse S. Smith","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041960498","display_name":"Kevin W. Kuntz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin K. Kuntz","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055002979","display_name":"Scott A. Ribich","orcid":"https://orcid.org/0009-0004-2325-8036","observed_orcids":["https://orcid.org/0009-0004-2325-8036"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott Ribich","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019354683","display_name":"Yukinori Minoshima","orcid":"https://orcid.org/0000-0002-6351-6624","observed_orcids":["https://orcid.org/0000-0002-6351-6624"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukinori Minoshima","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba, Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba, Ibaraki, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034541719","display_name":"Junji Matsui","orcid":"https://orcid.org/0000-0002-9983-9943","observed_orcids":["https://orcid.org/0000-0002-9983-9943"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junji Matsui","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba, Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba, Ibaraki, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103131022","display_name":"Robert A. Copeland","orcid":"https://orcid.org/0000-0003-2606-2288","observed_orcids":["https://orcid.org/0000-0003-2606-2288"]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Copeland","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057784648","display_name":"Shinya Tanaka","orcid":"https://orcid.org/0000-0001-6470-3301","observed_orcids":["https://orcid.org/0000-0001-6470-3301"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinya Tanaka","raw_affiliation_strings":["Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan","institution_ids":["https://openalex.org/I205349734"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078823930","display_name":"Heike Keilhack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heike Keilhack","raw_affiliation_strings":["Epizyme Inc., Cambridge, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme Inc., Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210109703"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000162907","https://openalex.org/A5055002979"],"corresponding_institution_ids":["https://openalex.org/I4210109703"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.3288,"has_fulltext":true,"cited_by_count":74,"citation_normalized_percentile":{"value":0.93374294,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"11","issue":"7","first_page":"e0158888","last_page":"e0158888"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synovial-sarcoma","display_name":"synovial sarcoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/ezh2-inhibition","display_name":"EZH2 inhibition","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tazemetostat","display_name":"tazemetostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ss18-ssx-fusion","display_name":"SS18-SSX fusion","score":0.8980000019073486},{"id":"https://openalex.org/keywords/smarcb1-loss","display_name":"SMARCB1 loss","score":0.9490000009536743},{"id":"https://openalex.org/keywords/polycomb-repressive-complex-2","display_name":"polycomb repressive complex 2","score":0.9789999723434448},{"id":"https://openalex.org/keywords/swi-snf-chromatin-remodeling","display_name":"SWI/SNF chromatin remodeling","score":0.9409999847412109},{"id":"https://openalex.org/keywords/h3k27me3","display_name":"H3K27me3","score":0.9629999995231628},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8920000195503235},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6779999732971191},{"id":"https://openalex.org/keywords/chromatin-remodeling","display_name":"chromatin remodeling","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.8344307541847229},{"id":"https://openalex.org/C2776915012","wikidata":"https://www.wikidata.org/wiki/Q17125871","display_name":"PRC2","level":5,"score":0.7501935362815857},{"id":"https://openalex.org/C2776910622","wikidata":"https://www.wikidata.org/wiki/Q2619315","display_name":"Synovial sarcoma","level":3,"score":0.6493252515792847},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.5687753558158875},{"id":"https://openalex.org/C167227067","wikidata":"https://www.wikidata.org/wiki/Q5113739","display_name":"Chromatin remodeling","level":4,"score":0.5245071649551392},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5093783140182495},{"id":"https://openalex.org/C150425827","wikidata":"https://www.wikidata.org/wiki/Q2560317","display_name":"Histone methyltransferase","level":4,"score":0.4488331973552704},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4205777645111084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40390825271606445},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.383323609828949},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19638168811798096},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.16549232602119446},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1280372440814972},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.11006340384483337},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071221","descriptor_name":"Enhancer of Zeste Homolog 2 Protein","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000071221","descriptor_name":"Enhancer of Zeste Homolog 2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000071221","descriptor_name":"Enhancer of Zeste Homolog 2 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000071796","descriptor_name":"SMARCB1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000071796","descriptor_name":"SMARCB1 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013584","descriptor_name":"Sarcoma, Synovial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013584","descriptor_name":"Sarcoma, Synovial","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013584","descriptor_name":"Sarcoma, Synovial","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015514","descriptor_name":"Oncogene Proteins, Fusion","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015514","descriptor_name":"Oncogene Proteins, Fusion","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063151","descriptor_name":"Polycomb Repressive Complex 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D063151","descriptor_name":"Polycomb Repressive Complex 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0158888","doi":"https://doi.org/10.1371/journal.pone.0158888","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0158888","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158888&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4154629","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5234811","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4938529","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4938529","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:27391784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27391784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmid:28085948","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28085948","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Published Erratum"},{"id":"pmh:oai:doaj.org/article:056beb7617a242fcb7ff5a42aa85f783","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/056beb7617a242fcb7ff5a42aa85f783","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 11, Iss 7, p e0158888 (2016)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/3906138","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Preclinical_Evidence_of_Anti-Tumor_Activity_Induced_by_EZH2_Inhibition_in_Human_Models_of_Synovial_Sarcoma/3906138","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0158888","doi":"https://doi.org/10.1371/journal.pone.0158888","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0158888","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158888&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323533","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2463147286.pdf","grobid_xml":"https://content.openalex.org/works/W2463147286.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W97378647","https://openalex.org/W1517116833","https://openalex.org/W1967717472","https://openalex.org/W1969559358","https://openalex.org/W1971313898","https://openalex.org/W1988450850","https://openalex.org/W1989623516","https://openalex.org/W1998807019","https://openalex.org/W2012227952","https://openalex.org/W2013204218","https://openalex.org/W2016991737","https://openalex.org/W2017325023","https://openalex.org/W2017492512","https://openalex.org/W2022093187","https://openalex.org/W2025847887","https://openalex.org/W2038208403","https://openalex.org/W2052747035","https://openalex.org/W2055468227","https://openalex.org/W2062247105","https://openalex.org/W2063851753","https://openalex.org/W2064494688","https://openalex.org/W2074694159","https://openalex.org/W2080504792","https://openalex.org/W2083298136","https://openalex.org/W2091208410","https://openalex.org/W2093247476","https://openalex.org/W2096187053","https://openalex.org/W2097733224","https://openalex.org/W2101304964","https://openalex.org/W2108740070","https://openalex.org/W2111905119","https://openalex.org/W2114033240","https://openalex.org/W2116036125","https://openalex.org/W2119079421","https://openalex.org/W2132310381","https://openalex.org/W2148297520","https://openalex.org/W2155309830","https://openalex.org/W2163261207","https://openalex.org/W2165932947","https://openalex.org/W2172177942","https://openalex.org/W2343896049","https://openalex.org/W2422151218","https://openalex.org/W2514201692"],"related_works":["https://openalex.org/W2767008663","https://openalex.org/W2343896049","https://openalex.org/W4386529360","https://openalex.org/W2741850853","https://openalex.org/W3179009923","https://openalex.org/W2190015925","https://openalex.org/W2468860270","https://openalex.org/W2797767731","https://openalex.org/W3127782183","https://openalex.org/W4282927137"],"abstract_inverted_index":{"The":[0,23],"catalytic":[1,129],"activities":[2,28,73],"of":[3,16,100,126,131,144,151,174,186,198,201,215,229],"covalent":[4],"and":[5,18,48,67,139,156,163,224],"ATP-dependent":[6],"chromatin":[7,17,53],"remodeling":[8],"are":[9,29],"central":[10],"to":[11,58,62,85,123,190],"regulating":[12],"the":[13,19,41,49,113,117,128,202,226],"conformational":[14],"state":[15],"resultant":[20],"transcriptional":[21],"output.":[22],"enzymes":[24],"that":[25,97],"catalyze":[26],"these":[27,233],"often":[30],"contained":[31],"within":[32],"multiprotein":[33,39],"complexes":[34],"in":[35,60,71,77,90,158,167,171,232],"nature.":[36],"Two":[37],"such":[38],"complexes,":[40],"polycomb":[42],"repressive":[43],"complex":[44,78,115],"2":[45],"(PRC2)":[46],"methyltransferase":[47],"SWItch/Sucrose":[50],"Non-Fermentable":[51],"(SWI/SNF)":[52],"remodeler":[54],"have":[55],"been":[56,83],"reported":[57],"act":[59],"opposition":[61],"each":[63],"other":[64],"during":[65],"development":[66],"homeostasis.":[68],"An":[69],"imbalance":[70],"their":[72],"induced":[74],"by":[75,105],"mutations/deletions":[76],"members":[79],"(e.g.":[80],"SMARCB1)":[81],"has":[82],"suggested":[84],"be":[86],"a":[87,136,149,178,213],"pathogenic":[88],"mechanism":[89],"certain":[91],"human":[92],"cancers.":[93,236],"Here":[94],"we":[95],"show":[96],"preclinical":[98],"models":[99,185],"synovial":[101,152,187,218],"sarcoma-a":[102],"cancer":[103],"characterized":[104],"functional":[106],"SMARCB1":[107],"loss":[108],"via":[109],"its":[110],"displacement":[111],"from":[112],"SWI/SNF":[114],"through":[116],"pathognomonic":[118],"SS18-SSX":[119,168],"fusion":[120],"protein-display":[121],"sensitivity":[122],"pharmacologic":[124],"inhibition":[125,162,194,197],"EZH2,":[127],"subunit":[130],"PRC2.":[132],"Treatment":[133,173],"with":[134,195],"tazemetostat,":[135],"clinical-stage,":[137],"selective":[138],"orally":[140],"bioavailable":[141],"small-molecule":[142],"inhibitor":[143],"EZH2":[145,221],"enzymatic":[146,222],"activity":[147,223],"reverses":[148],"subset":[150],"sarcoma":[153,188],"gene":[154],"expression":[155],"results":[157],"concentration-dependent":[159],"cell":[160,164,179],"growth":[161,193],"death":[165],"specifically":[166],"fusion-positive":[169],"cells":[170],"vitro.":[172],"mice":[175],"bearing":[176],"either":[177],"line":[180],"or":[181],"two":[182],"patient-derived":[183],"xenograft":[184],"leads":[189],"dose-dependent":[191],"tumor":[192],"correlative":[196],"trimethylation":[199],"levels":[200],"EZH2-specific":[203],"substrate,":[204],"lysine":[205],"27":[206],"on":[207,220],"histone":[208],"H3.":[209],"These":[210],"data":[211],"demonstrate":[212],"dependency":[214],"SS18-SSX-positive,":[216],"SMARCB1-deficient":[217],"sarcomas":[219],"suggests":[225],"potential":[227],"utility":[228],"EZH2-targeted":[230],"drugs":[231],"genetically":[234],"defined":[235]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-07-22T00:00:00"}